Literature DB >> 19026341

Inhaled nitric oxide and neuroprotection in preterm infants.

Jeremy D Marks1, Michael D Schreiber.   

Abstract

Although inhaled nitric oxide-mediated decreases in chronic lung disease and severe intraventricular hemorrhage/periventricular leukomalacia undoubtedly contribute to improved neurodevelopmental outcomes, inhaled nitric oxide has an independent neuroprotective effect. Although these data are encouraging, additional studies are required before recommending the routine use of inhaled nitric oxide for neuroprotection in preterm infants.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19026341      PMCID： PMC2717747          DOI： 10.1016/j.clp.2008.07.015

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN： 0095-5108            Impact factor:   3.430


  89 in total

Review 1.  Nitric oxide, mitochondria, and cell death.

Authors:  G C Brown; V Borutaite
Journal:  IUBMB Life       Date:  2001 Sep-Nov       Impact factor: 3.885

2.  Neurologic and developmental disability after extremely preterm birth. EPICure Study Group.

Authors:  N S Wood; N Marlow; K Costeloe; A T Gibson; A R Wilkinson
Journal:  N Engl J Med       Date:  2000-08-10       Impact factor: 91.245

3.  Neurodevelopmental outcome in high-risk preterm infants treated with inhaled nitric oxide.

Authors:  A J Bennett; N J Shaw; J E Gregg; N V Subhedar
Journal:  Acta Paediatr       Date:  2001-05       Impact factor: 2.299

4.  Nitric oxide inhalation in infants with respiratory distress syndrome.

Authors:  J W Skimming; K A Bender; A A Hutchison; W H Drummond
Journal:  J Pediatr       Date:  1997-02       Impact factor: 4.406

5.  Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

Authors:  J D Roberts; J R Fineman; F C Morin; P W Shaul; S Rimar; M D Schreiber; R A Polin; M S Zwass; M M Zayek; I Gross; M A Heymann; W M Zapol
Journal:  N Engl J Med       Date:  1997-02-27       Impact factor: 91.245

6.  Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.

Authors: 
Journal:  N Engl J Med       Date:  1997-02-27       Impact factor: 91.245

7.  Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia.

Authors:  Stephen A Back; Byung Hee Han; Ning Ling Luo; Charlene A Chricton; Steve Xanthoudakis; John Tam; Kara L Arvin; David M Holtzman
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

Review 8.  Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis.

Authors:  Y W Wu; J M Colford
Journal:  JAMA       Date:  2000-09-20       Impact factor: 56.272

9.  Early postnatal dexamethasone treatment and increased incidence of cerebral palsy.

Authors:  E S Shinwell; M Karplus; D Reich; Z Weintraub; S Blazer; D Bader; S Yurman; T Dolfin; A Kogan; S Dollberg; E Arbel; M Goldberg; I Gur; N Naor; L Sirota; S Mogilner; A Zaritsky; M Barak; E Gottfried
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-11       Impact factor: 5.747

10.  Nitric oxide in the human respiratory cycle.

Authors:  Timothy J McMahon; Richard E Moon; Ben P Luschinger; Martha S Carraway; Anne E Stone; Bryant W Stolp; Andrew J Gow; John R Pawloski; Paula Watke; David J Singel; Claude A Piantadosi; Jonathan S Stamler
Journal:  Nat Med       Date:  2002-06-03       Impact factor: 53.440
View more
  6 in total

1.  Safety and efficacy of inhaled nitric oxide treatment for premature infants with respiratory distress syndrome: follow-up evaluation at early school age.

Authors:  Athena I Patrianakos-Hoobler; Jeremy D Marks; Michael E Msall; Dezheng Huo; Michael D Schreiber
Journal:  Acta Paediatr       Date:  2010-12-01       Impact factor: 2.299

Review 2.  Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria.

Authors:  Chandy C John; Elizabeth Kutamba; Keith Mugarura; Robert O Opoka
Journal:  Expert Rev Anti Infect Ther       Date:  2010-09       Impact factor: 5.091

3.  Antenatal insults modify newborn olfactory function by nitric oxide produced from neuronal nitric oxide synthase.

Authors:  Alexander Drobyshevsky; Lei Yu; Yirong Yang; Syed Khalid; Kehuan Luo; Rugang Jiang; Haitao Ji; Matthew Derrick; Leslie Kay; Richard B Silverman; Sidhartha Tan
Journal:  Exp Neurol       Date:  2012-07-24       Impact factor: 5.330

4.  Association of NOS3 tag polymorphisms with hypoxic-ischemic encephalopathy.

Authors:  Radenka Kuzmanić Samija; Dragan Primorac; Biserka Resić; Bernarda Lozić; Vjekoslav Krzelj; Maja Tomasović; Eugenio Stoini; Ljubo Samanović; Benjamin Benzon; Marina Pehlić; Vesna Boraska; Tatijana Zemunik
Journal:  Croat Med J       Date:  2011-06       Impact factor: 1.351

5.  Acute traumatic cervical spinal cord injury in a third-trimester pregnant female with good maternal and fetal outcome: a case report and literature review.

Authors:  Ashok Reddy Pedaballe; Harvinder Singh Chhabra; Vikas Tandon; Parashuram Chauhan; Rachna Verma
Journal:  Spinal Cord Ser Cases       Date:  2018-10-23

6.  Hispidin inhibits LPS-induced nitric oxide production in BV-2 microglial cells via ROS-dependent MAPK signaling.

Authors:  Mei-Hua Jin; Dong-Qin Chen; Ying-Hua Jin; Ying-Hao Han; Hu-Nan Sun; Taeho Kwon
Journal:  Exp Ther Med       Date:  2021-07-07       Impact factor: 2.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.